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Abstract
Background: The aim of this study was to analyze the demographic, 
ethyological and clinical aspects of patients with liver cirrhosis treated 
in the Chronic Liver Disease Center. 
Methods: A descriptive, cross-sectional and retrospective study ba-
sed on the analysis of 580 pacients’ medical records with the diagnosis 
of hepatic cirrhosis treated from 2004 to 2014 in Belém, Brazil. 
Conclusions: The profile was predominantly of male patients, aged 
between 51 and 60 years, coming from the capital  Belem, whose 
main etiologies of cirrhosis were C hepatitis and alcohol. Ascites was 
the most frequent clinical manifestation and Child-Pugh score A was 
the most prevalent.
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Introduction
The liver plays a central role in the control of the 
human body [1]. The main histopathological charac-
teristic of liver injury is the deposition of extensive 
fibrosis with reduced liver function. Cirrhosis is the 
end result of fibrosis and, once present, the process 
is irreversible and predisposes to a high risk of mor-
tality [2]. 
The severity of liver disease is directly related to 
the extent of fibrosis, which determines the degree 
of stiffness of the liver. This degree varies according 
to the etiology of the disease, being the main ones: 
alcoholic, post-viral hepatitis, secondary to steato-
hepatitis [3]. 
Viral ethyologies are caused by hepatitis B, C and 
D virus infection. Alcoholic liver disease and hepa-
titis C are the most frequent causes of cirrhosis in 
developed countries of the West. In Asia and Africa, 
virus B is the main etiology of the disease. In addi-
tion, studies show that up to almost half of patients 
with cirrhosis are asymptomatic, making it difficult to 
diagnose early and determine the exact prevalence 
of the disease. In these, cirrhosis may be discovered 
during routine exams or at necropsy. However, once 
the symptoms manifest themselves, the prognosis is 
severe and the economic costs are high [4]. 
Hepatic cirrhosis accounts for a high morbidity 
and mortality rate, both in Brazil and worldwide [5]. 
According to the World Health Organization, the di-
sease is among the top 10 causes of death in adult 
individuals worldwide [6].It is important to empha-
size the early diagnosis of chronic liver diseases, so 
that immediate and appropriate treatment is adop-
ted, reducing the risk of progression to cirrhosis and 
later, for hepatocellular carcinoma, besides contribu-
ting to the reduction of the continuous transmission 
of infection in the liver. cases of viral hepatitis [7].
The aim of this study was to analyze the demo-
graphic, ethyological and clinical aspects of patients 
with liver cirrhosis treated in the Chronic Liver Di-
sease Center.
Methods
The sample was composed by patients attended at 
Chronic Liver Disease Center, in Belem (Brazil), from 
both genders, whose complementary exams (labo-
ratory, endoscopic, and/or ultrasonographic) were 
suggestive of cirrhosis, in the presence or absence 
of signs and symptoms of hepatic insufficiency or 
portal hypertension or histopathological examina-
tion of cirrhosis. The clinical diagnosis of cirrhosis 
was based on signs of portal hypertension (clinical 
or ultrasonographic) or hepatic insufficiency. A des-
criptive, cross-sectional and retrospective study in-
cluded data collected from patients diagnosed with 
cirrhosis attended in the center between January 
2004 and August 2014. Medical records of 580 pa-
tients were evaluated. The selected patients signed 
a Informed Consent Term and were submitted to 
clinical, epidemiological and histopathological eva-
luation with specific protocol. 
Results
The search results are distributed in the following 
eight tables.
Discussion
In this research, 62% of the patients were male, 
which is justified by a greater exposure of men to 
most risk factors [8, 9] and also because men attend 
less health services, thus, the evolution of undiag-
nosed fibrosis favors liver cirrhosis [10].
Age over 40 years old is a risk factor for fibrosis 
evolution [11]. In this study, 33% of the patients 
were between 51-60 years old. The advanced age in 
cirrhotic patients is justified by the slow progression 
of the disease in viral hepatitis, especially by hepatitis 
C virus (HCV) [12].
More than 70% of the patients come from urban 
areas. This suggests the possibility of under-repor-
ting of liver disease in rural areas, due to the lack of 
medical care in the country. In addition, this disease 
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Table 1.  Gender of cirrhotic patients attended at 
Chronic Liver Disease Center between 
2004 e 2014.
Gender N %
Female 218 38
Male 362 62
Total 580 100
Source: research protocol.
Table 5.  Clinical manifestations of cirrhotic patients 
attended at Chronic Liver Disease Center 
between 2004 e 2014.
Clinical manifestations N %
Ascites  215 37
Edema 186 32
Abdominal pain 163 28
Jaundice 139 24
Gastrointestinal disorder 135 23
Weight loss 105 18
Hemorrhagy 89 15
Fever 84 14
Spenomegaly 76 13
Paleness 76 13
Encephalopathy 74 13
Telangiectasia 51 9
Hepatomegaly 39 7
Palmar erythema 37 6
Choluria 25 4
Collateral circulation 24 4
Pruritus 19 3
Source: research protocol.
Table 4.  Ethyology related to cirrhotic patients at-
tended at Chronic Liver Disease Center bet-
ween 2004 e 2014.
Ethyology N %
Alcohol 196 43
HCV 139 31
HBV 56 12
Autoimmune 17 4
Idiopathic 15 3
Biliary 14 3
NASH 9 2
Others 10 2
Total 456 100
Source: research protocol.
Table 3.  Hometown region in state of Pará (Brazil) of 
cirrhotic patients attended at Chronic Liver 
Disease Center between 2004 e 2014.
Hometown region in state of Pará N %
Belem 278 73
North East 58 15
South East 23 6
Marajó 8 2
Baixo Amazonas 7 2
South West 4 1
Others 4 1
Total 382 100
Source: research protocol.
Table 2.  Age of cirrhotic patients attended at Chro-
nic Liver Disease Center between 2004 e 
2014.
Age N %
0 – 10 5 1
11 – 20 9 2
21 – 30 12 3
31 – 40 34 8
41 – 50 73 17
51 – 60 141 33
61 – 70 96 22
71 – 80 41 10
> 80 16 4
Total 427 100
Source: research protocol.
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Table 6.  Upper digestive endoscopy of cirrhotic pa-
tients attended at Chronic Liver Disease 
Center between 2004 e 2014.
Upper digestive endoscopy N %
Absence of esophageal varices 42 17
Presence of esophageal varices 205 83
Total 247 100
Source: research protocol.
Table 7.  Anti-HIVof cirrhotic patients attended at 
Chronic Liver Disease Center between 
2004 e 2014.
ANTI-HIV N %
Positive 5 11
Negative 46 89
Total 51 100
Source: research protocol.
Table 8.  Child-Pugh score of cirrhotic patients at-
tended at Chronic Liver Disease Center bet-
ween 2004 e 2014.
Child-Pugh score N %
A 35 42
B 28 34
C 20 24
Total 83 100
Source: research protocol.
has a urban pattern of infection, where there is a 
greater exposure to risk factors [12].
The most commom ethyology was alcoholic, fo-
llowed by C hepatitis, as observed in other studies 
[13, 14]. The ingestion of alcohol accelerates the 
frequency of hepatic decompensation, doubles the 
risk of mortality in cirrhotic patients, and there is a 
worsening of prognosis when there is an associa-
tion with other ethyologies1. Meanwhile the natural 
history of hepatitis C virus includes long asympto-
matic periods, which contributes a large number of 
patients to ignore this problem [15].
There were cases of co-infection between HIV and 
viral hepatitis. This association is a frequent event, 
due to the common risk factors in the transmission 
of these diseases. Viral hepatitis is the leading cau-
se of morbidity and mortality among HIV-infected 
patients. The progression rate of hepatic fibrosis in 
co-infected patients is about twice as fast as in pa-
tients infected only with B or D virus [16].
The most frequent clinical manifestations were as-
cites, edema and abdominal pain. Researches have 
shown that ascites is the main clinical manifestation 
of cirrhosis decompensation and approximately half 
of cirrhotic patients will develop ascites within 10 
years of follow-up [17]. Ascites occurs due to altera-
tions in the functioning of hepatocytes resulting in 
decreased albumin synthesis, which reduces plasma 
oncotic pressure and contributes to the formation 
of edema [18].
Another important finding was the presence of 
esophageal varices identified in the vast majority of 
patients by upper digestive endoscopy. In cirrhosis, 
portal hypertension leads to the development of 
esophageal varices, which is a very commom clinical 
manifestation found in studies with this group of 
patients [19].
The most frequent Child-Pugh score was A, 
followed by B and C. This result disagrees with 
other researches in hepatopathy specialized servi-
ces, which C is the most commom score [14]. The 
authors believe that due to the successful treatment 
and follow-up in this center, patients have lower 
scores.
Conclusion
The importance of cirrhosis in public health scena-
rio, due to its high morbidity, mortality and scarcity 
of regional information makes this research a way 
to contribute to a better understanding of regional 
aspects of this disease. Thus, it is emphasized the 
need for new studies that allow a deep analysis of 
this theme and optimize the quality of care to the 
population, particularly highlightning aspects rela-
ted to treatment and prevention.
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